Related Experiment Video
Updated: Feb 20, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Monitoring and managing antibiotic resistance in refugee children
Helena C Maltezou1, Dana Elhadad2, Daniel Glikman2,3
1a Department for Interventions in Health Care Facilities , Hellenic Center for Disease Control and Prevention , Athens , Greece.
Insights
Multi-drug resistant (MDR) pathogens and MDR-tuberculosis (TB) are significant concerns in refugee children. Routine screening and improved healthcare access are recommended to prevent transmission in new settings.
Area of Science:
- Public Health
- Infectious Diseases
- Pediatrics
Background:
- Middle East and Southeastern Europe have seen large refugee movements due to conflicts.
- Data on multi-drug resistant (MDR) bacterial carriage and infections, including MDR-tuberculosis (TB), in refugee children are limited.
- High MDR carriage rates in refugee children are linked to pre-war resistance, damaged infrastructure, and poor hygiene.
Purpose of the Study:
- To review available data on MDR bacterial carriage and infections in refugee children since 2010.
- To assess the prevalence and implications of MDR-tuberculosis (TB) in this population.
- To provide expert commentary and recommendations for screening and management.
Main Methods:
- Literature review focusing on pediatric data from 2010 onwards.
- Analysis of factors contributing to high MDR carriage rates.
- Evaluation of current TB screening practices in refugees.
Main Results:
- High rates of MDR bacterial carriage and infections observed in refugee children.
- Significant lack of international guidelines for MDR screening in this demographic.
- Limited data on MDR-TB prevalence in refugee children, despite high endemicity in their countries of origin.
Conclusions:
- Routine screening and contact isolation for refugees upon hospitalization are recommended due to the medical importance of MDRs.
- Standardized TB screening methods and target populations for refugees are needed.
- Integrated strategies including rapid diagnostics, improved healthcare access, cross-border collaboration, and protection during treatment are crucial for TB control.
Introduction:
The past decade the Middle East and Southeastern Europe have witnessed an enormous movement of refugees due to the Syrian war and conflicts in Asia and Africa. Although carriage of and infections with multi-drug resistant (MDR) pathogens in refugees have been reported, pediatric data are scarce. Areas covered: MDR bacterial carriage and infections, and MDR-tuberculosis (TB) in refugee children from 2010. Expert commentary: High MDR carriage rates in refugee children are attributed to high pre-civil war MDR rates, war-damaged infrastructure and healthcare systems, and poor hygiene conditions. Currently there are no international guidelines about MDR screening in refugee children. Given the medical importance of MDRs, challenging therapeutics and risk of importation in non/low-endemic countries, we recommend routine screening and contact isolation upon hospitalization of refugees. TB, including MDR-TB, is highly-endemic in many Asian and African countries, however, current data in refugee children are lacking. TB Screening in refugees is widely implemented but there is no consensus on methods and target populations. Coordinated TB detection and treatment, use of rapid molecular tests and drug-susceptibility testing, better access to healthcare, cross border TB care collaboration, and protection from deportation while on treatment should be integrated parts of TB control and prevention.
More Related Videos
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Related Concept Videos
Development of Antibiotic Resistance
Pharmacokinetics in Pediatric Patients: Drug Excretion
Antibiotic Selection
Urine Studies II: Urine Culture and Sensitivity Test
Acute Pyelonephritis II: Diagnostic Studies and Management